[Federal Register: August 9, 2007 (Volume 72, Number 153)]
[Notices]               
[Page 44861-44862]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09au07-90]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 9, 2007, and published in the Federal 
Register on March 23, 2007 (72 FR 13825), Sigma Aldrich Research, 
Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760, 
made application by letter to the Drug Enforcement Administration (DEA) 
to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed in schedule I:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Psilocybin (7437)..........................  I
5-Methoxy-N,N-diisopropyltyptamine (7439)..  I
------------------------------------------------------------------------

    The company plans on manufacturing reference standards for research 
purposes only.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code (U.S.C.) 823(a) and 
determined that the registration of Sigma Aldrich Research, 
Biochemicals, Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Sigma Aldrich Research, Biochemicals, Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection

[[Page 44862]]

and testing of the company's physical security systems, verification of 
the company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to Title 21, 
U.S.C. 823, and in accordance with Title 21, Code of Federal 
Regulations (CFR) 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic class of controlled 
substance listed.

    Dated: August 1, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-15507 Filed 8-8-07; 8:45 am]

BILLING CODE 4410-09-P